Literature DB >> 6179875

Evidence for a protective role of interferon in resistance to murine cytomegalovirus and its control by non-H-2-linked genes.

J E Grundy, J Trapman, J E Allan, G R Shellam, C J Melief.   

Abstract

Murine cytomegalovirus (MCMV) induces rapid production of a partially pH 2-stable type 1 interferon, the serum level of which is controlled by non-H-2-linked host genes. The production of high, intermediate, and low levels of interferon was found in C3H/He, C57BL/10, and BALB/c mice, respectively, and the use of H-2 congenic mice on the BALB/c or C57BL/10 background showed that H-2-associated genes were not involved. Administration of large (up to 200,000 U) daily doses of partially purified type 1 (alpha plus beta) interferon failed to protect low-producer BALB/c or BALB.K strains from lethal infection. Treatment of the higher (C3H/He) or intermediate (C57BL/10) producer strains with anti-type 1 interferon antibody significantly reduced their resistance to the virus; however, such treatment had no effect on the low-producer BALB/c strain. The decreased resistance of anti-interferon-treated C3H/He mice was accompanied by a transient reduction in serum interferon titers, decreased activation of natural killer cells, a markedly enhanced viremia, and increased viral titers in the liver. These data strongly support a protective role of interferon in defense against MCMV in certain strains of mice. Furthermore, these data suggest that previous observations of a correlation of non-H-2-linked, genetically determined resistance to MCMV with activation of natural killer cells may have its basis in the genetic control of interferon induction by MCMV.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6179875      PMCID: PMC347502          DOI: 10.1128/iai.37.1.143-150.1982

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  20 in total

1.  Production of interferon and serum hyporeactivity factor in mice infected with murine cytomegalovirus.

Authors:  G C Tarr; J A Armstrong; M Ho
Journal:  Infect Immun       Date:  1978-03       Impact factor: 3.441

2.  Alteration of host defense mechanisms by murine cytomegalovirus infection.

Authors:  D K Kelsey; G A Olsen; J C Overall; L A Glasgow
Journal:  Infect Immun       Date:  1977-12       Impact factor: 3.441

3.  Semi-micro, dye-binding assay for rabbit interferon.

Authors:  J A Armstrong
Journal:  Appl Microbiol       Date:  1971-04

4.  Influence of animal genotype and age on the amount of circulating interferoh induced by Newcastle disease virus.

Authors:  E De Maeyer; J De Maeyer-Guignard
Journal:  J Gen Virol       Date:  1968-05       Impact factor: 3.891

5.  Non-fatal mouse cytomegalovirus hepatitis. Combined morphologic, virologic and immunologic observations.

Authors:  D Henson; R D Smith; J Gehrke
Journal:  Am J Pathol       Date:  1966-11       Impact factor: 4.307

6.  Studies of relationship between mouse cytomegalovirus and interferon.

Authors:  J E Osborn; D N Medearis
Journal:  Proc Soc Exp Biol Med       Date:  1966-03

7.  Cellular origin of interferon induced by bacterial lipopolysaccharide.

Authors:  N Maehara; M Ho
Journal:  Infect Immun       Date:  1977-01       Impact factor: 3.441

8.  Murine cytomegalovirus: induction of and sensitivity to interferon in vitro.

Authors:  H K Oie; J M Easton; D V Ablashi; S Baron
Journal:  Infect Immun       Date:  1975-11       Impact factor: 3.441

9.  Resistance to murine cytomegalovirus linked to the major histocompatibility complex of the mouse.

Authors:  J E Chalmer; J S Mackenzie; N F Stanley
Journal:  J Gen Virol       Date:  1977-10       Impact factor: 3.891

10.  Suppressed response to interferon inducation in mice infected with encephalomyocarditis virus, Semliki forest virus, influenza A2 virus, Herpesvirus hominis type 2, or murine cytomegalovirus.

Authors:  D A Stringfellow; E R Kern; D K Kelsey; L A Glasgow
Journal:  J Infect Dis       Date:  1977-04       Impact factor: 5.226

View more
  28 in total

1.  Natural killer cell-produced IFN-γ and TNF-α induce target cell cytolysis through up-regulation of ICAM-1.

Authors:  Ruipeng Wang; Jessica J Jaw; Nicole C Stutzman; Zhongcheng Zou; Peter D Sun
Journal:  J Leukoc Biol       Date:  2011-11-01       Impact factor: 4.962

Review 2.  Modulation of host innate and adaptive immune defenses by cytomegalovirus: timing is everything.

Authors:  A Loewendorf; C A Benedict
Journal:  J Intern Med       Date:  2010-05       Impact factor: 8.989

Review 3.  The tiers and dimensions of evasion of the type I interferon response by human cytomegalovirus.

Authors:  Lisi Amsler; Marieke Verweij; Victor R DeFilippis
Journal:  J Mol Biol       Date:  2013-09-05       Impact factor: 5.469

Review 4.  Sources and signals regulating type I interferon production: lessons learned from cytomegalovirus.

Authors:  Shilpi Verma; Chris A Benedict
Journal:  J Interferon Cytokine Res       Date:  2011-01-12       Impact factor: 2.607

Review 5.  Animal cytomegaloviruses.

Authors:  J Staczek
Journal:  Microbiol Rev       Date:  1990-09

6.  Interferon-alpha/beta inhibition of interleukin 12 and interferon-gamma production in vitro and endogenously during viral infection.

Authors:  L P Cousens; J S Orange; H C Su; C A Biron
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

Review 7.  Molecular biology and immunology of cytomegalovirus.

Authors:  P D Griffiths; J E Grundy
Journal:  Biochem J       Date:  1987-01-15       Impact factor: 3.857

8.  Interferon structural genes do not participate in quantitative regulation of interferon production by If loci as shown in C57BL/6 mice that are congenic with BALB/c mice at the alpha interferon gene cluster.

Authors:  J De Maeyer-Guignard; F Dandoy; D W Bailey; E De Maeyer
Journal:  J Virol       Date:  1986-06       Impact factor: 5.103

9.  Selective impairment of alpha-interferon-mediated natural killer augmentation in Sjögren's syndrome: differential effects of alpha-interferon, gamma-interferon, and interleukin 2 on cytolytic activity.

Authors:  A Takeda; N Minato; S Kano
Journal:  Clin Exp Immunol       Date:  1987-11       Impact factor: 4.330

10.  Lymphoid-tissue stromal cells coordinate innate defense to cytomegalovirus.

Authors:  Shilpi Verma; Qiao Wang; Grzegorz Chodaczek; Chris A Benedict
Journal:  J Virol       Date:  2013-03-27       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.